Freeline Therapeutics Holdings plc (NASDAQ:FRLN – Free Report) – Analysts at Wedbush cut their Q3 2023 earnings per share (EPS) estimates for Freeline Therapeutics in a note issued to investors on Tuesday, August 15th. Wedbush analyst D. Nierengarten now expects that the company will earn ($3.89) per share for the quarter, down from their prior […] The post Freeline Therapeutics Holdings plc (NASDAQ:FRLN) Expected to Earn Q3 2023 Earnings of ($3.89) Per Share first appeared on Daily Political .

https://www.dailypolitical.com/2023/08/18/freeline-therapeutics-holdings-plc-nasdaqfrln-expected-to-earn-q3-2023-earnings-of-3-89-per-share.html

#dailypolitical